FDA Grants Priority Review of sBLA for KRYSTEXXA and Methotrexate
Suneet Grewal, MD, a rheumatologist at East Bay Rheumatology Medical Group in the Bay Area discusses the supplemental Biologics License Application (sBL...
5262 articles
Suneet Grewal, MD, a rheumatologist at East Bay Rheumatology Medical Group in the Bay Area discusses the supplemental Biologics License Application (sBL...
Robert Hummel, Chief Operating Officer at Suvoda, a global clinical trial technology company, discusses the rise in trial complexity, how the focus has ...
Eric Brouwer, Ph.D., Chief Scientific Officer at SQI Diagnostics, a company focused on the science of lung health, discusses the development and manufac...
Jeffrey Dlott, Medical Director at Quest Direct discusses the new "Future of Personalized Healthcare Insights Study 2022" that was conducted by Leaf Gro...
Mark Berman, Chief Medical Officer of Better Therapeutics discusses how prescription digital therapeutics (PDTs) could reimagine how we treat type 2 dia...
Tony Mack, Chairman and CEO of Virpax Pharma, discusses a new drug candidate in the pipeline that uses the Intranasal MET-nanoparticle dispersion deli...
Telehealth at UpHealth and founder of Martti™ by UpHealth, a telehealth platform that includes language access discusses how language barriers affe...
Angela Carroll, US Medical Affairs Scientific Director-Immuno-inflammation at GlaxoSmithKline (GSK), a global health care company, discusses...
Eric Bednash, CEO and co-founder of RackTop Systems, an innovative cyber security company, discusses protecting data within the healthcare industry, esp...
Antonia Chen, Director of Research for the Division of Adult Reconstruction and Total Joint Arthroplasty in the Department of Orthopaedic Surgery at Bri...